Amblyopia in children aged 7 to 17 years.
Phillips
Calbert I
CI
D000293:Adolescent; D000550:Amblyopia / Q000628:therapy*; D001285:Atropine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003131:Combined Modality Therapy; D005139:Eyeglasses; D005500:Follow-Up Studies; D006801:Humans; D009184:Mydriatics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012683:Sensory Deprivation; D016896:Treatment Outcome; D015348:Vision, Binocular / Q000502:physiology; D014792:Visual Acuity / Q000502:physiology
D009184:Mydriatics; D001285:Atropine